Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Suzanne, Bakdash"'
Publikováno v:
American Journal of Clinical Pathology. 159:34-42
Objectives Visual inspection of posttransfusion plasma for hemolysis is a key laboratory method in the investigation of possible acute hemolytic transfusion reactions (AHTRs). Many substances and physiologic conditions can mimic hemolysis in vitro. I
Autor:
Gösta B. Pettersson, Suzanne Bakdash, Brett J. Wakefield, Rachel Diehl, Anand Mehta, Anne T. Neff
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 35:1154-1160
Preoperative thrombocytopenia is associated with an increased risk of morbidity and mortality following cardiothoracic surgery. We describe a case of a 28-year-old female with a history of myosin heavy chain 9-related disease (MYH9-RD) and a presenti
Publikováno v:
American Journal of Clinical Pathology. 155:133-140
ObjectivesWhen our institution grew into an integrated multihospital health system, we were faced with the need to standardize laboratory processes, including blood bank processes, across all locations. The purpose of this article is to describe our
Autor:
Shiva Sale, Mariya Geube, Jeevanantham Rajeswaran, Eugene H. Blackstone, Douglas R. Johnston, Suzanne Bakdash, Eric E. Roselli
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 164(5)
Objective To evaluate the effect of autologous whole blood (AWB) collection on intraoperative/postoperative allogeneic blood transfusion rate in complex aortic surgery with hypothermic circulatory arrest. Methods This retrospective study included adu
Autor:
Aaron A.R. Tobian, Patricia A. R. Brunker, Mark H. Yazer, Darrell J. Triulzi, Samantha Harris, Suzanne Bakdash, Meghan Delaney, Victorea Earnest
Publikováno v:
Transfusion. 56:2502-2509
BACKGROUND By consensus definition, the red blood cells (RBCs) of patients that react weak to 2+ in the serologic D test are classified as having the serologic weak D phenotype (weak D). The risk of D alloimmunization in patients with weak D is not w
Autor:
Gonzalo V. Gonzalez-Stawinski, William M. Baldwin, Amy S. Nowacki, Lynne Klingman, Aiwen Zhang, David O. Taylor, Medhat Askar, Eileen Hsich, Nicholas G. Smedira, Randall C. Starling, Suzanne Bakdash, Jenna Daghstani, Nader Moazami, Patrick K. Reville
Publikováno v:
The Journal of Heart and Lung Transplantation. 32:1241-1248
Ventricular assist devices (VADs) are increasingly being used as a bridge to transplantation and have been implicated as a risk factor for allosensitization to human leukocyte antigens (HLA). We investigate the association between VAD and allosensiti
Autor:
Mark H, Yazer, Patricia A, Brunker, Suzanne, Bakdash, Aaron A R, Tobian, Darrell J, Triulzi, Victorea, Earnest, Samantha, Harris, Meghan, Delaney
Publikováno v:
Transfusion. 56(10)
By consensus definition, the red blood cells (RBCs) of patients that react weak to 2+ in the serologic D test are classified as having the serologic weak D phenotype (weak D). The risk of D alloimmunization in patients with weak D is not well studied
Autor:
Miguel Regueiro, Sheldon I. Bastacky, James B. McGee, John M. Lyons, Robert E. Schoen, Suzanne Bakdash, Kenneth K. Lee, Michael A. Pezzone, Franklin A. Bontempo
Publikováno v:
American Journal of Hematology. 83:411-415
Publikováno v:
The Coagulation Consult ISBN: 9781461495598
Dysregulation of one or more elements in hemostatic system can cause an increased risk of bleeding or hypercoagulability (thrombosis). Highly complex platelets play an important role in hemostasis and thrombosis through adhesion to subendothelium, re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05a9ec66b66df52db9b7098ec5e56d09
https://doi.org/10.1007/978-1-4614-9560-4_1
https://doi.org/10.1007/978-1-4614-9560-4_1
Autor:
Kandice Kottke-Marchant, Eric Novak, Deepak L. Bhatt, Jeremiah P. Depta, Suzanne Bakdash, Jeffrey Fowler, Irene L. Katzan
Publikováno v:
Stroke. 43(9)
Background and Purpose— Antiplatelet therapy nonresponse is associated with worse clinical outcomes. We studied the clinical outcomes associated with platelet function-guided modifications in antiplatelet therapy in patients with ischemic stroke or